Salarius Pharmaceuticals Inc (SLRX) — Defensive Interval Ratio

Latest as of June 2023: 13 days

Salarius Pharmaceuticals Inc (SLRX) has a Defensive Interval Ratio of 13 days as of June 2023. Defensive assets of $130.00K (cash $-, short-term investments $-, receivables $130.00K) cover 13 days of daily cash needs of $9.98K/day. See working capital to net assets of Salarius Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

13 days
Days of operational coverage

Defensive Assets

$130.00K
Cash + ST Investments + Receivables

Daily Cash Need

$9.98K
Current Liabilities ÷ 365

Current Liabilities

$3.64 Million
USD

Salarius Pharmaceuticals Inc Defensive Interval Ratio (2015–2022)

This chart shows how Salarius Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2015 to 2022. As of June 2023, the ratio stands at 13 days, meaning defensive assets of $130.00K can fund 13 days of operations without new revenue. See how leveraged is Salarius Pharmaceuticals Inc's balance sheet to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Salarius Pharmaceuticals Inc (2015–2022)

The table below presents the year-by-year Defensive Interval Ratio for Salarius Pharmaceuticals Inc from 2015 to 2022, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see SLRX company net worth.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2022 138 days $1.61 Million $11.69K/day $- $- ▼ -370 days
2020 508 days $3.86 Million $7.60K/day $- $- ▲ +507 days
2018 1 days $9.94K $13.74K/day $- $0.00 ▼ -882 days
2017 883 days $14.14 Million $16.02K/day $- $14.13 Million ▼ -2747 days
2016 3629 days $38.67 Million $10.66K/day $- $38.66 Million ▲ +469 days
2015 3160 days $24.65 Million $7.80K/day $- $24.65 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)